Maravai LifeSciences Holdings Inc MRVI Fundamentals and Key Ratios

Home
Investing
Stocks
USA
NASDAQ
Maravai LifeSciences Holdings Inc (MRVI)
Financials

Maravai LifeSciences Holdings Inc. (MRVI) Fundamentals


Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

SHARE INFORMATION
Market Cap	$ 1,874,439,899
Shares Outstanding	131,539,642
Float	89,146,271
Percent Float	67.77%
Short Interest	0.00
Short Percent Float	0.0%
Short Interest Ratio	0.00
Short Interest Date	-
Latest Fiscal Dividend Per Share	$ 0.00
Latest Fiscal Revenue	$ 799,240,000
Latest Fiscal EPS	$ 1.55
Latest Fiscal Date	2021-12-31

DIVIDENDS
Dividend (3 Years)	$ 0.00
Dividend (5 Years)	$ 0.00
Ex Dividend Date	-
Dividend Rate	$ 0.00
Dividend Yield	0.0%
Payment Cash	-

HOLDERS
Institutions	562
Institutional Holdings Date	2022-10-31
Institutional Bought Previous 3 Months	16,007,638
Institutional Holdings Percent	172.1%
Institutional Sold Previous 3 Months	26,160,216
Insider Holdings Date	2022-10-31
Insider Bought Previous 3 Months	992,039
Insider Holdings Percent	0.6
Insider Sold Previous 3 Months	-
Insider Shares Owned	809,551

TRADING INFO
52 Week High	$ 46.29
52 Week Low	$ 13.41
52 Week High Change	$ -60.95
21 Day Moving Average	$ 15.0805
21 Day Extended Moving Average	$ 15.3639
50 Day Moving Average	$ 18.7277
50 Day Extended Moving Average	$ 17.8867
200 Day Moving Average	$ 27.5366
200 Day Extended Moving Average	$ 25.8166
10 Day Average Volume	2,533,452
20 Day Average Volume	2,379,711
30 Day Average Volume	2,173,998
50 Day Average Volume	2,304,378
Alpha	-0.005174
Beta	-0.2374
Standard Deviation	0.184819
R2	0.004666
7 Day Price Change	$ -0.10
7 Day Percent Change	-0.7%
21 Day Price Change	$ -1.11
21 Day Percent Change	-7.23%
30 Day Price Change	$ -2.43
30 Day Percent Change	-14.57%
Month to Date Price Change	$ -2.35
Month to Date Percent Change	-14.16%
Quarter to Date Price Change	$ -11.28
Quarter to Date Percent Change	-44.18%
180 Day Price Change	$ -21.44
180 Day Percent Change	-60.07%
200 Day Price Change	$ -18.12
200 Day Percent Change	-55.98%
Year to Date Price Change	$ -27.65
Year to Date Percent Change	-65.99%

Maravai LifeSciences Holdings Inc. (MRVI) Key Ratios

PROFITABILITY
EBIT Margin	68.1%
EBITDA Margin	71.2%
Pre-Tax Profit Margin	0.0%
Profit Margin Count	58.44%
Gross Margin	82.9%
Profit Margin TOT	58.44%

INCOME STATEMENTS
Revenue	$ 906,732,000
Revenue Per Share	$ 6.8932
Revenue (3 Years)	$ 0.00
Revenue (5 Years)	$ 0.00

FINANCIAL STRENGTH
Price to Tangible Book	-706.20
Total Debt To Equity	1.10
Int Coverage	35.80
Current Ratio	7.20
Leverage Ratio	5.00
Quick Ratio	6.50
Long Term Debt To Capital	0.51

VALUATION MEASURES
PE Ratio	8.00
Enterprise Value	$ 1,804,244,862
Price to Sales	2.0672
Price to Free Cash	7.90
PE High Last 5 Years	0.00
Price To Book	3.80
Price To Cash Flow	7.40
PE Low Last 5 Years	0.00
Price to Tangible Book	-706.20

MANAGEMENT EFFECTIVENESS
Receivables Turnover	9.70
Invoice Turnover	2.80
Assets Turnover	0.50
Return Assets	12.37
Return on Equity	62.73
Return on Capital	26.32

Maravai LifeSciences Holdings Inc. (MRVI) Profile

PROFILE INFO
Issue Type	CS
SEC Type	-
Auditor	Ernst & Young LLP
CEO	Carl W. Hull / William Martin
Emplyoees	550
Last Audit	UE
CIK	0001823239
Industry	Biotechnology
Sector	Healthcare
NAICS	Research and Development in Biotechnology (except Nanobiotechnology)(541714)

CONTACT INFO
Address	10770 Wateridge Circle Suite 200 San Diego, CA 92121
Website	https://www.maravai.com
Facsimile	-
Telephone	+1 858 546-0004
Email	david.weber@maravai.com

Quotes:

IHub: